— Know what they know.
Not Investment Advice

PSTX NASDAQ

Poseida Therapeutics, Inc.
1W: -1.0% 1M: +1.5% 3M: +269.6% 1Y: +194.1% 3Y: +38.5%
$9.50
Last traded 2025-01-08 — delisted
NASDAQ · Healthcare · Biotechnology · $925.9M mcap · 65M float · 2.78% daily turnover

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
48.9 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 81.1%
Cost Advantage ★
63
Intangibles
55
Switching Cost
48
Network Effect
43
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PSTX shows a Weak competitive edge (48.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 81.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$10
Low
$10
Avg Target
$10
High
Based on 1 analyst since Nov 7, 2024 earnings
Analyst Recommendations
Strong Buy: 0Buy: 3Hold: 3Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2024-12-02 Piper Sandler Edward Tenthoff Initiated $10 — +7.4% $9.31
2023-01-04 H.C. Wainwright — Initiated $15 — +159.1% $5.79

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 39 Grade D
Profitability
57
Balance Sheet
52
Earnings Quality
43
Growth
88
Value
29
Momentum
80
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PSTX scores highest in Growth (88/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-1.55
Distress Zone
Piotroski F-Score
5/9
✗ ✗ ✓ ✓ ✓ ✗ ✗ ✓ ✓
Beneish M-Score
2.10
Possible Manipulator
Ohlson O-Score
-5.13
Bankruptcy prob: 0.6%
Low Risk
Credit Rating
B
Score: 30.0/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.25x
Accruals: -14.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PSTX scores -1.55, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PSTX scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PSTX's score of 2.10 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PSTX's implied 0.6% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PSTX receives an estimated rating of B (score: 30.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-6.93x
PEG
-0.08x
P/S
14.31x
P/B
8.26x
P/FCF
-16.40x
P/OCF
—
EV/EBITDA
-2.88x
EV/Revenue
0.88x
EV/EBIT
-2.57x
EV/FCF
-7.75x
Earnings Yield
-21.15%
FCF Yield
-6.10%
Shareholder Yield
0.18%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. PSTX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.978
NI / EBT
×
Interest Burden
1.176
EBT / EBIT
×
EBIT Margin
-0.342
EBIT / Rev
×
Asset Turnover
0.506
Rev / Assets
×
Equity Multiplier
2.826
Assets / Equity
=
ROE
-56.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PSTX's ROE of -56.3% is driven by Asset Turnover (0.506), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.98 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1132 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$9.50
Median 1Y
$4.94
5th Pctile
$0.88
95th Pctile
$27.29
Ann. Volatility
105.7%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
ROE -11.6% -13.2% -32.0% -63.5% -56.7% -60.5% -88.9% -1.2% -18.2% -38.7% -36.5% -30.4% -78.1% -84.7% -88.8% -1.1% -56.3% -56.34%
ROA -8.5% -9.3% -21.8% -39.6% -37.9% -39.5% -50.7% -57.9% -10.4% -21.4% -17.0% -12.6% -38.9% -39.5% -37.3% -38.4% -19.9% -19.94%
ROIC -2.0% -2.2% -2.9% -8.9% -7.9% -8.8% -8.4% -7.5% -75.6% 7.7% 19.2% -2.9% 3.7% 4.4% 3.1% 1.0% 81.1% 81.06%
ROCE -8.9% -20.2% -34.8% -56.6% -69.2% -53.8% -69.1% -83.3% -7.2% -19.2% -13.9% -9.0% -54.4% -56.6% -56.2% -52.8% -24.0% -23.99%
Gross Margin — — — — — 0.1% 15.9% 53.3% 98.8% 86.3% 87.2% 93.0% 84.6% 83.3% 95.1% 94.8% 1.0% 1.00%
Operating Margin — — — — — -56.0% -39.7% -15.4% 61.7% -3.3% -3.8% -1.4% -3.9% -1.0% -87.3% -1.2% 27.5% 27.52%
Net Margin — — — — — 4.7% -41.2% -16.5% 60.5% -3.4% -3.9% -1.4% -3.4% -96.0% -86.3% -1.2% 28.2% 28.20%
EBITDA Margin — — — — — 111.8% -38.9% -14.9% 63.4% -3.0% -3.4% -1.2% -3.0% -86.6% -73.3% -1.1% 33.3% 33.30%
FCF Margin — — — — — -3367.0% -80.3% -30.2% -20.4% -23.5% -12.5% -7.0% -1.3% -1.5% -86.9% 0.2% -11.4% -11.35%
OCF Margin — — — — — -3282.6% -78.3% -29.6% -17.2% -20.5% -9.7% -4.5% -1.2% -1.4% -84.0% 2.8% -10.0% -9.96%
ROE 3Y Avg snapshot only -63.62%
ROE 5Y Avg snapshot only -57.34%
ROA 3Y Avg snapshot only -24.30%
ROIC Economic snapshot only -29.58%
Cash ROA snapshot only -5.12%
NOPAT Margin snapshot only -32.73%
Pretax Margin snapshot only -40.25%
R&D / Revenue snapshot only 1.12%
SGA / Revenue snapshot only 27.13%
SBC / Revenue snapshot only 15.27%
Valuation
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
P/E Ratio -14.17 -19.69 -8.13 -5.26 -3.59 -3.39 -1.90 -1.11 -8.14 -6.84 -5.58 -5.00 -1.65 -2.46 -2.85 -2.54 -4.73 -6.934
P/S Ratio — — — — — 13729.99 191.14 38.84 2.25 3.49 1.91 0.98 4.41 4.68 3.71 3.20 1.86 14.311
P/B Ratio 1.65 2.59 2.60 3.34 3.02 2.75 2.70 2.46 1.25 2.43 1.69 1.13 1.77 2.92 3.62 4.66 3.22 8.262
P/FCF -15.18 -10.50 -5.68 -4.55 -3.11 -4.08 -2.38 -1.28 -11.01 -14.84 -15.25 -13.94 -3.42 -3.18 -4.27 1335.56 -16.40 -16.402
P/OCF — — — — — — — — — — — — — — — 115.14 — —
EV/EBITDA -6.24 -6.38 -3.71 -3.03 -2.04 -2.42 -1.39 -0.83 -4.40 -5.04 -3.36 -1.65 -0.56 -1.62 -2.04 -1.32 -2.88 -2.877
EV/Revenue — — — — — 9084.15 129.56 26.59 0.68 2.01 0.76 0.16 1.33 2.72 2.33 1.46 0.88 0.880
EV/EBIT -6.11 -6.22 -3.61 -2.95 -1.99 -2.33 -1.35 -0.80 -3.47 -4.59 -2.88 -1.22 -0.54 -1.54 -1.93 -1.24 -2.57 -2.571
EV/FCF -6.38 -6.63 -3.69 -3.26 -2.17 -2.70 -1.61 -0.88 -3.35 -8.53 -6.11 -2.30 -1.03 -1.85 -2.68 608.39 -7.75 -7.753
Earnings Yield -7.1% -5.1% -12.3% -19.0% -27.8% -29.5% -52.6% -90.3% -12.3% -14.6% -17.9% -20.0% -60.7% -40.7% -35.1% -39.3% -21.1% -21.15%
FCF Yield -6.6% -9.5% -17.6% -22.0% -32.1% -24.5% -42.0% -77.9% -9.1% -6.7% -6.6% -7.2% -29.3% -31.4% -23.4% 0.1% -6.1% -6.10%
Price/Tangible Book snapshot only 3.440
EV/Gross Profit snapshot only 0.922
Shareholder Yield snapshot only 0.18%
Leverage & Solvency
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Current Ratio 11.67 10.46 9.86 7.51 6.44 4.94 4.34 3.69 6.64 5.54 5.35 4.61 3.28 3.18 2.56 2.48 3.20 3.203
Quick Ratio 11.67 10.46 9.86 7.51 6.44 4.94 4.34 3.69 6.64 5.54 5.35 4.61 3.28 3.18 2.56 2.48 3.20 3.203
Debt/Equity 0.20 0.23 0.27 0.33 0.40 0.39 0.90 1.39 0.42 0.47 0.56 0.64 0.70 0.82 1.00 1.38 0.95 0.949
Net Debt/Equity -0.96 -0.95 -0.91 -0.94 -0.92 -0.93 -0.87 -0.78 -0.87 -1.03 -1.01 -0.94 -1.23 -1.22 -1.35 -2.53 -1.70 -1.698
Debt/Assets 0.15 0.16 0.19 0.20 0.23 0.23 0.38 0.45 0.24 0.25 0.28 0.31 0.29 0.31 0.32 0.28 0.28 0.282
Debt/EBITDA -1.79 -0.88 -0.60 -0.41 -0.39 -0.52 -0.68 -0.69 -4.84 -1.71 -2.78 -5.69 -0.74 -0.78 -0.90 -0.85 -1.79 -1.792
Net Debt/EBITDA 8.59 3.72 2.01 1.20 0.89 1.24 0.66 0.38 10.06 3.73 5.04 8.33 1.30 1.16 1.21 1.57 3.21 3.209
Interest Coverage -39.58 -40.51 -41.90 -44.72 -47.25 -36.22 -39.23 -32.06 -4.53 -8.96 -5.04 -2.62 -14.63 -13.22 -11.22 -11.50 -5.69 -5.691
Equity Multiplier 1.37 1.42 1.47 1.60 1.74 1.72 2.39 3.12 1.76 1.88 1.99 2.08 2.44 2.64 3.10 4.91 3.37 3.366
Cash Ratio snapshot only 2.949
Debt Service Coverage snapshot only -5.087
Cash to Debt snapshot only 2.791
FCF to Debt snapshot only -0.207
Defensive Interval snapshot only 425.6 days
Efficiency & Turnover
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.38 0.42 0.50 0.64 0.15 0.21 0.29 0.31 0.51 0.506
Inventory Turnover — — — — — — — — — — — — — — — — — —
Receivables Turnover — — — — — — — 35.92 6.26 28.69 33.01 25.80 2.11 7.15 8.06 7.27 12.88 12.882
Payables Turnover 0.00 135.67 42.06 23.46 43.63 0.70 1.16 0.90 1.09 0.92 1.56 1.89 1.85 3.04 2.85 3.28 1.78 1.784
DSO — — — — — 0 0 10 58 13 11 14 173 51 45 50 28 28.3 days
DIO — 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO — 3 9 16 8 522 314 406 335 395 234 193 197 120 128 111 205 204.5 days
Cash Conversion Cycle — — — — — -522 -314 -396 -277 -382 -223 -179 -24 -69 -83 -61 -176 -176.2 days
Fixed Asset Turnover snapshot only 4.142
Cash Velocity snapshot only 0.653
Capital Intensity snapshot only 1.946
Growth (YoY)
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue — — — — — — — — — 4172.2% 94.0% 36.6% -58.8% -50.4% -40.8% -43.5% 2.0% 2.04%
Net Income — — — — -2.7% -2.7% -1.0% -23.3% 73.7% 47.3% 67.7% 79.1% -3.0% -85.4% -1.3% -2.6% 55.3% 55.26%
EPS — — — — -2.2% -2.6% -1.0% -22.2% 78.6% 61.4% 76.5% 84.9% -2.3% -76.7% -1.0% -2.3% 58.1% 58.14%
FCF — — — — -3.5% -62.8% -13.0% 7.9% 83.2% 70.8% 85.2% 91.3% -1.6% -2.1% -3.1% 1.0% 73.3% 73.26%
EBITDA — — — — -3.7% -74.4% -31.8% 9.7% 87.9% 55.7% 76.8% 88.5% -5.3% -1.1% -2.0% -5.4% 60.6% 60.58%
Op. Income — — — — -2.7% -2.7% -1.0% -20.9% 78.4% 51.6% 70.4% 79.4% -4.1% -1.2% -1.7% -3.1% 54.3% 54.32%
OCF Growth snapshot only 75.38%
Asset Growth snapshot only -2.87%
Equity Growth snapshot only -29.48%
Debt Growth snapshot only -4.10%
Shares Change snapshot only 6.88%
Growth (CAGR)
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue 3Y — — — — — — — — — — — — — — — — — —
Revenue 5Y — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — -9.3% -9.7% -7.6% -0.0% 3.9% 3.87%
Assets 5Y — — — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — -25.2% -26.6% -28.1% -31.2% -16.6% -16.57%
Book Value 3Y — — — — — — — — — — — — -37.0% -35.3% -37.9% -40.7% -28.3% -28.31%
Dividend 3Y — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue Stability — — — — — — — — 0.75 0.75 0.76 0.77 0.37 0.45 0.54 0.52 0.52 0.521
Earnings Stability — — — — — — — — 0.00 0.12 0.06 0.53 0.22 0.35 0.00 0.13 0.03 0.033
Margin Stability — — — — — — — — — — — — — 0.00 0.00 0.29 0.95 0.955
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.50 0.81 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — 0.33 0.12 0.57 1.20 -0.58 -0.61 -0.41 -0.61 -0.07 -0.067
Gross Margin Trend — — — — — — — — — — — — — 54.31 1.12 0.36 0.03 0.026
FCF Margin Trend — — — — — — — — — — — — — 1682.12 39.33 15.16 0.63 0.634
Sustainable Growth Rate — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
OCF/Net Income 0.85 1.73 1.36 1.10 1.12 0.81 0.78 0.84 0.62 0.40 0.28 0.23 0.46 0.75 0.64 -0.02 0.25 0.253
FCF/OCF 1.10 1.08 1.05 1.05 1.03 1.03 1.03 1.02 1.19 1.15 1.29 1.56 1.05 1.03 1.03 0.09 1.14 1.140
FCF/Net Income snapshot only 0.288
CapEx/Revenue — — — — — 84.3% 2.0% 60.9% 3.2% 3.0% 2.8% 2.5% 6.1% 4.7% 2.9% 2.5% 1.4% 1.39%
CapEx/Depreciation snapshot only 0.383
Accruals Ratio -0.01 0.07 0.08 0.04 0.04 -0.07 -0.11 -0.09 -0.04 -0.13 -0.12 -0.10 -0.21 -0.10 -0.13 -0.39 -0.15 -0.149
Sloan Accruals snapshot only -0.029
Cash Flow Adequacy snapshot only -7.144
Dividends & Buybacks
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — 0.0% — —
Total Payout Ratio — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.0% 0.0% 0.2% 0.18%
Net Buyback Yield 0.0% 0.0% -0.1% -0.1% -0.5% -0.6% -1.0% -1.7% -28.2% -16.7% -28.7% -49.9% -7.1% -0.3% -0.3% -0.3% -4.8% -4.83%
Total Shareholder Return 0.0% 0.0% -0.1% -0.1% -0.5% -0.6% -1.0% -1.7% -28.2% -16.7% -28.7% -49.9% -7.1% -0.3% -0.3% -0.3% -4.8% -4.83%
DuPont Factors
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.02 1.09 1.05 1.08 1.07 1.01 1.00 0.99 0.99 0.98 0.978
Interest Burden (EBT/EBIT) 1.03 0.50 0.68 0.78 0.79 1.04 1.04 1.04 1.28 1.11 1.20 1.38 1.07 1.08 1.09 1.09 1.18 1.176
EBIT Margin — — — — — -3893.21 -96.25 -33.06 -0.20 -0.44 -0.27 -0.13 -2.47 -1.77 -1.21 -1.17 -0.34 -0.342
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.38 0.42 0.50 0.64 0.15 0.21 0.29 0.31 0.51 0.506
Equity Multiplier 1.37 1.42 1.47 1.60 1.50 1.53 1.76 2.00 1.75 1.81 2.15 2.42 2.01 2.15 2.38 2.96 2.83 2.826
Per Share
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
EPS (Diluted TTM) $-0.63 $-0.56 $-1.17 $-1.91 $-2.03 $-2.01 $-2.35 $-2.33 $-0.43 $-0.77 $-0.55 $-0.35 $-1.44 $-1.37 $-1.12 $-1.15 $-0.60 $-0.60
Book Value/Share $5.38 $4.24 $3.67 $3.00 $2.41 $2.48 $1.66 $1.05 $2.82 $2.18 $1.83 $1.56 $1.35 $1.15 $0.88 $0.63 $0.89 $1.15
Tangible Book/Share $5.28 $4.15 $3.58 $2.91 $2.32 $2.39 $1.57 $0.96 $2.75 $2.12 $1.76 $1.49 $1.29 $1.09 $0.82 $0.57 $0.83 $0.83
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.02 $0.07 $1.57 $1.52 $1.61 $1.80 $0.54 $0.72 $0.86 $0.91 $1.54 $0.72
FCF/Share $-0.58 $-1.04 $-1.68 $-2.20 $-2.34 $-1.67 $-1.88 $-2.01 $-0.32 $-0.36 $-0.20 $-0.13 $-0.70 $-1.06 $-0.75 $0.00 $-0.17 $-1.06
OCF/Share $-0.53 $-0.96 $-1.59 $-2.09 $-2.27 $-1.63 $-1.84 $-1.97 $-0.27 $-0.31 $-0.16 $-0.08 $-0.66 $-1.02 $-0.72 $0.03 $-0.15 $-1.02
Cash/Share $6.21 $5.00 $4.36 $3.82 $3.18 $3.28 $2.93 $2.27 $3.64 $3.29 $2.87 $2.47 $2.60 $2.35 $2.07 $2.45 $2.35 $2.35
EBITDA/Share $-0.60 $-1.09 $-1.67 $-2.37 $-2.49 $-1.86 $-2.18 $-2.12 $-0.24 $-0.60 $-0.37 $-0.18 $-1.27 $-1.21 $-0.98 $-1.01 $-0.47 $-0.47
Debt/Share $1.07 $0.96 $1.00 $0.98 $0.97 $0.97 $1.49 $1.46 $1.18 $1.03 $1.02 $1.00 $0.94 $0.95 $0.88 $0.86 $0.84 $0.84
Net Debt/Share $-5.14 $-4.04 $-3.36 $-2.84 $-2.21 $-2.30 $-1.44 $-0.81 $-2.46 $-2.25 $-1.85 $-1.47 $-1.66 $-1.41 $-1.19 $-1.59 $-1.51 $-1.51
Academic Models
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Altman Z-Score — — — — — — — — — — — — — — — — — -1.548
Altman Z-Prime snapshot only -2.892
Piotroski F-Score 2 1 1 1 0 2 2 2 4 5 6 6 1 1 2 4 5 5
Beneish M-Score — — — — — — — — — 278.45 2.24 8.20 -4.31 -2.07 -1.97 -4.21 2.10 2.101
Ohlson O-Score snapshot only -5.134
ROIC (Greenblatt) snapshot only -24.73%
Net-Net WC snapshot only $0.45
Credit
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Credit Rating snapshot only B
Credit Score 46.95 49.74 43.72 33.71 29.04 29.38 28.50 27.04 36.95 37.68 29.66 29.72 30.23 29.96 29.99 28.67 29.96 29.957
Credit Grade snapshot only 15
Credit Trend snapshot only -0.277
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 21
Sector Credit Rank snapshot only 21

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms